(Q37790448)

23 August 2017

title

A review of hereditary and acquired coagulation disorders in the aetiology of ischaemic stroke (English)

1 reference

23 August 2017

Lonneke M L de Lau

1

1 reference

23 August 2017

Frank W G Leebeek

2

1 reference

23 August 2017

Moniek P M de Maat

3

1 reference

23 August 2017

Peter J Koudstaal

4

1 reference

23 August 2017

Diederik W J Dippel

5

1 reference

23 August 2017

publication date

1 October 2010

1 reference

International Journal of Stroke

23 August 2017

published in

1 reference

23 August 2017

volume

5

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

385-394

1 reference

Risk factors for ischaemic stroke.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Cryptogenic stroke: time to determine aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Inherited thrombophilia in ischemic stroke and its pathogenic subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Diagnostic testing for coagulopathies in patients with ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Arterial thrombosis and the role of thrombophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Ischemic stroke due to protein C deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Association of hemostatic variables with MRI-detected cerebral abnormalities: the atherosclerosis risk in communities study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Thrombophilia and first arterial ischaemic stroke: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Recurrent venous thromboembolism in patients with a partial deficiency of protein S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Advances in understanding pathogenic mechanisms of thrombophilic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Prothrombotic phenotype of protein Z deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Frequency of protein Z deficiency in patients with ischaemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Protein Z in ischemic stroke and its etiologic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Protein Z gene polymorphisms are associated with protein Z plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Antiphospholipid antibiodies: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Clinical laboratory testing for the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Västerbotten cohort project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Antiphospholipid antibodies in young adults with stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Cerebrovascular complications in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

The pattern of cancer in a large cohort of stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Stroke in patients with cancer: incidence and etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

The hypercoagulable state of malignancy: pathogenesis and current debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Stroke and cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

First-ever stroke as initial presentation of systemic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Homocysteine-lowering therapy: a role in stroke prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Is plasma homocysteine a modifiable risk factor for stroke?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Homocysteine lowering with folic acid and B vitamins in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Homocysteine lowering and cardiovascular events after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Homocysteine and stroke prevention: have the trials settled the issue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Efficacy of folic acid supplementation in stroke prevention: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

von Willebrand factor, endothelial dysfunction, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

High von Willebrand Factor Levels Increase the Risk of First Ischemic Stroke: Influence of ADAMTS13, Inflammation, and Genetic Variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Thrombotic thrombocytopenic purpura: MRI demonstration of persistent small cerebral infarcts after clinical recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Major stroke in thrombotic-thrombocytopenic purpura (Moschcowitz syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Smoking and the platelet fibrinogen receptor glycoprotein IIb/IIIA PlA1/A2 polymorphism interact in the risk of lacunar stroke and midterm survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

PLA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIa in young patients with cryptogenic TIA or ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Fibrinolysis and the risk of venous and arterial thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Hypofibrinolysis is a risk factor for arterial thrombosis at young age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Risk of ischemic stroke associated with functional thrombin-activatable fibrinolysis inhibitor plasma levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

The PAI-1 4G/5G gene polymorphism and ischemic stroke: an association study and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Patent foramen ovale and cerebrovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Prevalence of Patent Foramen Ovale in Patients with Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Ischemic stroke risk with oral contraceptives: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Venous thromboembolism and atherosclerosis: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

An association between atherosclerosis and venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Imaging the cellular biology of the carotid plaque.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Inherited thrombophilia in arterial disease: a selective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Is plasma fibrinogen useful in evaluating ischemic stroke patients?: why, how, and when.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

Protein Z Gene Polymorphisms, Protein Z Concentrations, and Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2010.00468.X

10.1111/J.1747-4949.2010.00468.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference